Business / Finance

RSS

Acusis agrees to purchase SPi medical transcription business

Acusis, LLC, a leader in medical transcription solutions, announces that it has agreed to purchase the medical transcription assets of SPi America LLC/SPi Technologies, Inc. (SPi), a global business process outsourcing company with headquarters in the Philippines.

5 Aug 2011

P&G fourth quarter net sales increase 10% to $20.9 billion

The Procter & Gamble Company net sales grew 10 percent to $20.9 billion for the fourth quarter and five percent to $82.6 billion for fiscal 2011.

5 Aug 2011

GenMark Diagnostics second quarter revenues increase to $901,000

GenMark Diagnostics, Inc. today reported financial results for the second quarter ended June 30, 2011.

5 Aug 2011

World RNA Interference market will be worth $4 billion by 2017: New report

By 2017, the world RNA Interference market will be worth $4 billion, according to a new report available from companiesandmarkets.com.

5 Aug 2011

Sirona third quarter revenue increases 34.1% to $244.7 million

Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.

5 Aug 2011

OncoGenex second quarter revenue increases to $1.9 million

OncoGenex Pharmaceuticals, Inc. today provided an update on current events and activities and announced its second quarter financial results.

5 Aug 2011

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.

4 Aug 2011

ArQule second quarter net loss increases to $10,804,000

ArQule, Inc. today announced its financial results for the second quarter of 2011.

4 Aug 2011

Health Care REIT second quarter normalized FFO up 13% to $0.90 per share

Health Care REIT, Inc. today announced operating results for the company's second quarter ended June 30, 2011.

4 Aug 2011

MOCON second quarter net sales increase 24% to $9,082,000

MOCON, Inc. today reported its operating results for the second quarter ended June 30, 2011.

4 Aug 2011

Valeant second quarter total revenue increases to record $609.4 million

Valeant Pharmaceuticals International, Inc. announces second quarter financial results for 2011.

4 Aug 2011

Health Net second quarter total revenues decrease 19.2% to $2.8 billion

Health Net, Inc. today announced 2011 second quarter GAAP net income of $58.3 million, or $0.63 per diluted share, compared with $45.1 million, or $0.45 per diluted share, for the second quarter of 2010.

4 Aug 2011

Micromet second quarter total revenues increase to $7.1 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

Transcend second quarter revenue increases 38% to $30,662,000

Transcend Services, Inc., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.

4 Aug 2011

SXC second quarter revenue increases 153% to $1.2 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month and six-month periods ended June 30, 2011.

4 Aug 2011

Columbia Laboratories second quarter total net revenues increase to $19.2 million

Columbia Laboratories, Inc. today reported financial results for the three- and six-month periods ended June 30, 2011.

4 Aug 2011

CIGNA consolidated revenues increase 7% for second quarter 2011

CIGNA Corporation today reported second quarter 2011 results, that included strong revenue growth and earnings from each of our ongoing businesses, reflecting continued effective execution of the fundamentals supporting our long-term growth strategy.

4 Aug 2011

BioCryst second quarter total revenues decrease to $3.7 million

BioCryst Pharmaceuticals, Inc. announced financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

SynCo Bio commences release of drug products after expansion of Class A zone

SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.

4 Aug 2011

Prestige Brands Holdings first quarter revenues increase 33.8% to $95.3 million

Prestige Brands Holdings, Inc. today announced results for the first fiscal quarter ended June 30, 2011, including revenues of $95.3 million, an increase of 33.8% over the prior year comparable period's results of $71.2 million.

4 Aug 2011